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Abstract
Background: We investigated vision status associated with trachomatous trichiasis (TT) and
explored age-sex patterns of low vision and blindness associated with trichiasis in Mankien district
of southern Sudan where trachoma prevention and trichiasis surgery were absent.
Methods:  A population based survey was undertaken and eligible persons underwent eye
examination. Visual acuity (VA) was tested using Snellen E chart and persons with TT identified.
Vision status was defined using the WHO categories of visual impairment based on presenting VA:
normal vision (VA ≥ 6/18 in better eye); low vision (VA < 6/18 but ≥ 3/60 in better eye); and
blindness (VA < 3/60 in better eye). An ordinal logistic regression model was fitted and age/sex
specific distribution of vision status predicted.
Results: Overall 341/3,567 persons examined had any TT. Analysis was based on 319 persons, 22
persons were excluded: 20 had both TT and cataract; and 2 had missing VA data. Of the 319
persons: 158(49.5%) had trichiasis-related corneal opacity (CO); bilateral TT and bilateral CO were
found in 251(78.7%) and 110 (34.5%), respectively; 146 (45.8%) had low vision or blindness; the
ratio of low vision to blindness was 3.2:1; and no sex differences were observed. In our model the
predicted distribution of vision status was: normal vision, 53.9% (95% CI 50.9–56.9); low vision,
35.3% (95% CI 33.3–37.2); and blindness, 10.9% (95% CI 9.7–12.0).
Conclusion: We have reported severe trichiasis and high prevalence of vision loss among persons
with trichiasis. Our survey showed that almost 1 in 20 of the entire population suffered low vision
or blindness associated with trachoma. The need for trichiasis surgery, trachoma prevention
services, and rehabilitation of the blind is acute.
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Background
The World Health Organization (WHO) estimates that
1.3 million people world wide are blind due to trachoma
[1] and 7.6 million have trichiasis, the potentially blind-
ing stage of the disease, in 55 countries [2]. In southern
Sudan, the magnitude and prevalence of active trachoma
and trachomatous trichiasis (TT) are among the highest in
the world. In areas surveyed so far, mean prevalence of
active trachoma in children aged 1–9 years was 64% while
trichiasis prevalence in persons aged 15 years and above
was 9.2%, thus making blinding trachoma a severe public
health problem [3]. Trichiasis is generally accepted to
commence in the second and third decades of life with up
to 10% of adults in endemic communities being affected
[4-6]. However, early onset of trichiasis has been observed
in southern Sudan with a mean trichiasis prevalence of
1.4% in children aged under 15 years and individuals as
young as four years affected [3,7].
Recurrent infection with ocular Chlamydia trachomatis
results in chronic inflammation, scarring, trichiasis, and
corneal opacification [8-10]. Trachomatous blindness is
due to irreversible corneal damage arsing from physical
corneal abrasion, corneal infections and defective tear
film [4,5]. Blindness mainly results from corneal opacity
(CO) that obscures the visual axis, and is graded on exam-
ination of the eye by the presence of an opacity which is
dense enough to obscure the pupil margin. Although
vision loss has also been observed in individuals with
peripheral corneal opacity [11] trichiasis alone, in the
absence of overt corneal opacity, can result in substantial
visual impairment and disability [12]. Previous studies
estimating the global burden of trachoma have indicated
paucity of data on trachomatous low vision and blindness
and suggest the need for population based studies to esti-
mate low vision and blindness arising from trachoma [13-
15]. The objective of this study was to investigate vision
status in persons with trichiasis and to explore the age and
sex patterns of low vision and blindness associated with
trichiasis.
Methods
Study setting and participants
This study was conducted in Mankien payam (district) of
southern Sudan. The sample size and sampling plan has
been described previously [7,16]. In brief, a population
based survey was conducted to estimate the prevalence of
blindness, low vision, active trachoma and trichiasis. A
two-stage cluster random sampling design was used to
select the sample: villages were selected in stage one and
households selected in stage two. A total of 3,567 persons
who were present in the selected households underwent
eye examination. The analysis presented here comprises
persons of all ages and sexes presenting with any TT.
Ocular examination
Clinical examination of the eyes was undertaken by qual-
ified integrated eye care workers (IECWs) who had been
trained in visual acuity testing and trachoma grading by
an experienced ophthalmic nurse. The examiners' reliabil-
ity was validated with the ophthalmic nurse as the gold-
standard. Only examiners who had an inter-observer
agreement of at least 80% were eligible to participate in
the survey.
Visual acuity testing and basic eye examination
Prior to the survey, the minimum age for visual acuity
(VA) testing was predetermined to be 5 years. VA testing
was conducted outdoors in adequate sunlight using the
Snellen E chart at 6 meters. In persons with VA < 6/60, VA
was evaluated with the Snellen chart at 3 meters. Further
VA assessment was done in persons with VA < 3/60 by
counting fingers, hand movement and light perception as
appropriate. All participants then underwent basic eye
examination. Using a torch and a ×2.5 magnifying binoc-
ular loupe, each eye was examined first for in-turned
lashes (TT), and the cornea was then inspected for corneal
opacities (CO), and the lens examined for cataract. TT was
defined as the presence of at least one eyelash touching
the eyeball or evidence of epilation of eyelashes; CO was
defined as easily visible opacity that obscured the papil-
lary margin; and cataract was defined as an opacity of the
lens that appeared greyish or white when examined with
oblique light, under a shaded area [17].
Data were recorded on a customized form and the cause
of visual impairment determined for all subjects with a
presenting VA of < 6/18 for each eye separately. The prin-
cipal disorder responsible low vision or blindness was
determined for the participant by taking into account the
main cause for each individual eye. Vision loss was attrib-
uted to trachoma in persons presenting with trichiasis and
corneal opacity. In the instance where different causes of
vision loss had been identified for each eye separately in a
given individual, the principal disorder was chosen to be
the one that was most readily curable or, if not curable,
most easily preventable (i.e. cataract, trachoma, non-tra-
chomatous CO, and other causes in that order).
Definition of vision status
The WHO categories of visual impairment were used to
define individual vision outcomes (vision status) [18].
Blindness was defined as a presenting visual acuity of less
than 3/60 in the better eye. Low vision was defined as pre-
senting visual acuity of less than 6/18 but equal to or
greater than 3/60 in the better eye. Normal vision was
defined to represent persons who had normal or near-nor-
mal vision in the better eye (VA ≥ 6/18). An ordinal score
of vision status comprising of three categories was then
assigned to all eligible participants based on increasingBMC Ophthalmology 2007, 7:12 http://www.biomedcentral.com/1471-2415/7/12
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severity of visual impairment: where '1' was normal
vision; '2' low vision; and '3' blindness.
Statistical analysis
Data were double entered by different entry clerks and
compared for consistency using EpiInfo version 3.3.2
(CDC, Atlanta, Georgia). Statistical analysis was con-
ducted using Stata 8.2 (Stata Corporation, College Sta-
tion, Texas). Contingency table analysis was used to
examine demographic characteristics. Differences in age/
sex distribution and proportions were tested using χ2 test.
Age specific distributions of vision status were calculated
for 5-year age intervals. We fitted an ordinal logistic
regression model to the observed data to explore the age
and sex distribution of the three categories of vision sta-
tus: normal vision; low vision; and blindness [19]. Per-
sons with vision loss not attributable to trichiasis were
excluded from the final model. Children aged 0–4 years
were assumed to have normal vision. Predicted probabil-
ities were derived to smooth age-specific curves for the
three categories of vision status [20].
Ethical consideration
The Sudan Peoples Liberation Movement Secretariat of
Health (SPLM/Health) and the Institutional Review Board
of Emory University approved the protocol and clearance
to conduct the surveys was obtained from the local
authorities. Verbal consent to participate was sought from
the head of the household and from each individual and
the parents of children aged 10 years and below in accord-
ance with the declaration of Helsinki. Personal identifiers
were removed from the data set before analyses were
undertaken. Participants who required surgical interven-
tion or further assessment were referred to attend an eye
surgical camp that was organised and conducted after the
survey.
Results
Characteristics of the study participants
The prevalence of TT, CO, and vision loss attributable to
trachoma among the 3,567 people surveyed are shown in
Figure 1 and Figure 2. The following analysis relates to
people in whom trachomatous trichiasis (TT) was
detected. A total of 341 persons (9.6% of 3,567 exam-
ined) were found to have any trachomatous trichiasis
(TT). Of the 341 persons with any TT, 22 were excluded
from the analysis: 20 had both TT and cataract making it
impossible to determine which condition was responsible
for the visual acuity findings; and 2 had missing visual
acuity (VA) data (Figure 3). Six persons with trichiasis and
CO in one eye had non-trachomatous CO in the contra-
lateral eye and were included in the analysis. Three chil-
dren with TT aged 0–4 years, who were not eligible for VA
examination, were assumed to have normal vision. Preva-
lence of cataract in the general population was 4.9% (122/
2,499) [16], which was not statistically different to preva-
lence of cataract in the population with TT, which was
5.9% (20/341) (P = 0.43).
Among the 319 persons with TT included in the analysis:
males and females comprised 117 (36.7%) and 202
(63.3%), respectively; mean age of was 37.2 years (stand-
ard deviation = 18.4); and median age was 39 years (inter-
quartile range = 21–50). Trichiasis-related corneal opacity
(CO) was detected in 159 (49.8%); and bilateral TT and
CO were found in 251(78.7%) and 110 (34.5%), respec-
tively. The proportion of persons with TT presenting with
CO increased with age.
Distribution of vision status
Observed distribution of vision status
The observed distribution of vision status is shown on
Table 1. Overall 54.2% (95% CI = 48.6–59.8) had normal
vision, 34.8% (95% CI = 29.6–40.3) had low vision, and
11.0% (95% CI = 7.8–14.9) had blindness. There was no
sex difference in the overall distribution of observed vis-
ual status (P = 0.95). In 173 persons presenting with nor-
Age specific prevalence of trachomatous trichiasis and cor- neal opacity (n = 3,567) Figure 1
Age specific prevalence of trachomatous trichiasis and cor-
neal opacity (n = 3,567).
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mal vision (VA > 6/18 in the better eye), 46 (26.6%) had
visual impairment (VA < 6/18) in the other eye. The sever-
ity of visual impairment increased with age with all per-
sons aged 65 years and above presenting with either low
vision or blindness.
Predicted distribution of vision status
Table 2 and Figure 4 show the predicted distribution of
vision status. Overall 53.9 (95% CI = 50.9–56.9) had nor-
mal vision, 35.3% (95% CI = 33.3–37.2) had low vision;
and 10.9% (95% CI = 9.7–12.0) had blindness. Consist-
ent with the observed data, no sex differences were
observed in the overall predicted distribution of vision
status (P = 0.62) and severity of visual impairment
increased with age. The ratio of low vision to blindness
was 3.2:1 (95%CI = 2.6:1 to 3.5:1). Sensitivity analysis of
distribution of vision status in persons with TT, including
those with vision loss due to cataract showed results sim-
ilar to those presented (data not shown).
Discussion
This study provides a contemporary survey of the relation-
ship between trachomatous trichiasis and visual impair-
ment (low vision and blindness) in southern Sudan. In a
trachoma hyper-endemic area of southern Sudan, which
was not previously accessible during the civil war, one in
10 persons had trichiasis [7]. Trichiasis was found to be
severe in nature in a sample of 319 persons: nearly four
fifths had bilateral trichiasis; one in eight were children
aged less than 15 years; a third had low vision; and one in
10 had blindness. The study revealed that a half of all per-
sons with trichiasis could be expected to have low vision
or blindness by the time they reach their late thirties. This
epidemiologic picture is consistent with a severe burden
of trichiasis and vision loss at a much younger age than
had been appreciated. It is also indicative of lack of trich-
iasis surgery services in this area, and shows a substantial
backlog of trichiasis cases that need to be operated and
blind persons who need to be rehabilitated. Determining
visual acuity is important in understanding the patterns of
visual impairment associated with trichiasis and will assist
in planning and priority setting for trichiasis surgery serv-
ices. The study revealed that over half of the persons with
trichiasis had normal vision in the better eye. While
resources will undoubtedly be inadequate to provide
timely surgery for all, priority should be given to those
with some residual vision, since that gives the best chance
Sample population Figure 3
Sample population. *Three children aged 0–4 years 
assumed to have normal vision. VA, visual acuity.
3,567 persons underwent eye examination
341 persons with 
Trachomatous Trichiasis (TT)
22 Excluded:
20 persons with both TT and Cataract
2 adults with TT and missing VA data
319 persons with TT included in 
modelling distribution of vison status*
Age specific prevalence of vision loss attributable to tra- choma (n = 3,567) Figure 2
Age specific prevalence of vision loss attributable to 
trachoma (n = 3,567). Normal vision = presenting visual 
acuity of ≥ 6/18 in the better eye; Low vision = presenting 
visual acuity of < 6/18 to ≤ 3/60 in the better eye; Blindness = 
presenting visual acuity of < 3/60 in the better eye. Three 
children aged 0–4 years assumed to have normal vision.
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of saving years-of-useful-sight. Trichiasis in children is
most likely predictive of a massive future burden of tra-
chomatous blindness and calls for urgent measures for
trachoma control. It is very important to identify and
recruit children with trichiasis for surgery and to tailor
trichiasis surgery services to cater for the young who may
require a general anaesthetic [21].
Our study explored vision loss associated with trichiasis.
It is possible that some individuals develop trachomatous
CO and vision loss without trichiasis, or CO develops first
followed by trichiasis [22]. In addition, some people with
few inturned lashes effectively epilate the offending lashes
making it difficult to detect trichiasis, thus leading to
under estimation of trichiasis prevalence [23]. It may not
be possible to distinguish corneal opacity from causes
other than trachoma e.g. trauma, measles, Xerophthal-
mia, herpetic eye disease; but these account for a minor
proportion of CO compared to trachoma. In central Tan-
zania, CO without trichiasis was observed to be more
prevalent in women below 35 years [22]. It is probable
that in trachoma hyper-endemic settings like Mankien,
the majority of corneal opacities or phthisis in persons
aged 30 years and above, even in the absence of trichiasis,
are due to trachoma. Therefore, estimation of vision loss
due to trachoma by assessing related CO in the presence
of visible trichiasis on examination is likely to underesti-
mate the burden of blindness attributable to trachoma.
We assumed that children aged 0–4 years presenting with
trichiasis did not have vision loss. Measurement of visual
acuity in this age group is particularly difficult [24]; and
most of the available assessment techniques are not prac-
tical under field settings. Trichiasis in young children
highlights the severity of blinding trachoma in Mankien:
further specialised assessment of vision status in these
children is suggested.
Consistent with findings from other countries in sub-
Saharan Africa [1,25] cataract (41%) was the leading
cause of blindness in Mankien [16]. Trachoma accounted
for 35% of blindness and two thirds of all forms of vision
loss, which by far exceeds that observed in other trachoma
endemic settings [16,25]. This probably underscores the
way uncontrolled trachoma can ravage inaccessible and
underserved communities. In our analysis we excluded
persons with both TT and cataract thus demonstrating the
Table 1: Frequency distribution of observed vision status by age group and sex in persons with trichiasis (n = 319)
Age 
group 
(years)
Vision status* (n)
Males Females Total
Normal 
vision
Low 
vision
Blindness Total Normal 
vision
Low 
vision
Blindness Total Normal 
vision
Low 
vision
Blindness Total
0–4** 0 0 0 0 3 0 0 3 3 0 0 3
5 – 9 8 0 0 8 1 30 0 1 3 2 100 2 1
10–14 8 1 0 9 9 0 0 9 17 1 0 18
15–19 12 1 0 13 8 3 0 11 20 4 0 24
20–24 10 5 1 16 5 2 0 7 15 7 1 23
25–29 1 2 1 4 12 4 0 16 13 6 1 20
30–34 4 3 0 7 16 9 1 26 20 12 1 33
35–39 6 4 0 10 11 2 2 15 17 6 2 25
40–44 1 0 0 1 9 6 2 17 10 6 2 18
45–49 10 3 0 13 12 6 6 24 22 9 6 37
50–54 4 8 0 12 7 17 3 27 11 25 3 39
55–59 0 8 2 10 1 3 1 5 1 11 3 15
60–64 0 2 5 7 3 9 2 14 3 11 7 21
65–69 0 2 1 3 0 4 2 6 0 6 3 9
70–74 0 1 2 3 0 4 1 5 0 5 3 8
75+ 0 1 0 1 0 1 3 4 0 2 3 5
Total: n 64 41 12 117 109 70 23 202 173 111 35 319
Total: % 54.7 35.0 10.3 54.0 34.7 11.4 54.2 34.8 11.0
95% CI 45.2–63.9 26.5–44.4 5.4–17.2 46.8–61.0 28.1–41.7 7.3–16.6 48.6–59.8 29.6–40.3 7.8–14.9
*Vision status: Normal vision = presenting visual acuity of ≥ 6/18 in the better eye; Low vision = presenting visual acuity of < 6/18 to ≤ 3/60 in the 
better eye; Blindness = presenting visual acuity of < 3/60 in the better eye.
**Three children aged 0–4 years assumed to have normal vision.BMC Ophthalmology 2007, 7:12 http://www.biomedcentral.com/1471-2415/7/12
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pattern of vision loss attributable mainly to trachoma.
There was no evidence to suggest that persons with trichi-
asis were more likely to have cataract compared to the
general population. However, it is possible that some of
the low vision observed among the population with TT
was not caused by the TT since other conditions leading to
visual impairment such as refractive error were not con-
trolled for. Our study showed overall distribution of low
vision and blindness among trichiasis patients consistent
with that observed in The Gambia (38% low vision and
7% blindness)[8] and Ethiopia (39.6% low vision and
10.6% blindness)[26]. However, these two studies were
not population based and investigated patients presenting
for TT surgery. It is possible that patients presenting for
surgery were likely to have more severe trichiasis or vision
loss compared to those not presenting, thus resulting in
higher proportions of persons with low vision.
We did not find any differences in the distribution of pro-
portions of vision status by sex in patients with trichiasis;
however, there were many more women who had trichia-
sis compared to men. Active trachoma, through re-infec-
tion, is an important factor in the pathologic process of
progression from TS to TT [9]. Scarring complications
have been reported to be higher in women than men in
many cross-sectional studies [3,7,10,27,28]. It is believed
that greater exposure of women to young children, who
are the reservoir for active infection, accounts for the
female excess in risk of trachomatous complications.
However, exposure to children amongst women may be
more important in the development of trachomatous
scarring (TS) than progression of TS to TT and CO [29].
The severe nature of trachomatous vision loss in Mankien
possibly results from early scarring with subsequent pro-
gression to trichiasis and rapid progression of vision loss
in persons with trichiasis. This alarming epidemiological
picture results from the complex interaction between the
host and environmental factors. Nonetheless, the specific
host and environmental factors that predispose people in
southern Sudan, especially children, to such overwhelm-
ing levels of blinding trachoma merit further investiga-
tion. The ultimate intervention goal for TT surgery is to
reduce the prevalence of TT cases to less than 1/1,000 total
population [30]. Nonetheless, until the prevalence of
active trachoma is reduced for a sustained period, thus
eliminating incident cicatrizing trachoma, trachoma will
continue to be an important cause of vision loss in south-
ern Sudan.
Table 2: Distribution of predicted proportions of vision status by age group and sex in persons with trichiasis (n = 319)
Age group 
(years)
Vision status* (%)
Males Females Total
Normal 
vision
Low vision Blindness Normal 
vision
Low vision Blindness Normal 
vision
Low vision Blindness
0–4** 100.0 0 0 100 0 0 100 0 0
5–9 94.6 5.0 0.4 96.3 3.3 0.3 96.0 3.7 0.4
1 0 – 1 4 9 0 . 19 . 2 0 . 79 3 . 16 . 2 0 . 79 2 . 46 . 9 0 . 7
15–19 83.9 14.8 1.3 88.4 10.4 1.2 87.4 11.4 1.2
20–24 76.1 21.8 2.1 82.2 15.8 2.0 80.9 17.2 2.0
25–29 67.2 29.7 3.2 74.7 22.3 3.0 72.9 24.0 3.1
30–34 57.6 37.7 4.7 66.0 29.4 4.5 64.1 31.4 4.5
35–39 48.2 45.1 6.7 56.9 36.6 6.5 54.8 38.6 6.5
40–44 39.4 51.3 9.3 47.9 43.0 9.1 45.8 45.0 9.1
45–49 31.7 55.7 12.6 39.4 48.2 12.4 37.6 50.1 12.4
50–54 25.2 58.2 16.5 32.0 51.6 16.4 30.3 53.3 16.4
55–59 19.9 58.9 21.2 25.6 53.3 21.1 24.2 54.8 21.1
60–64 15.6 57.9 26.5 20.3 53.1 26.6 19.1 54.4 26.4
65–69 12.2 55.4 32.4 16.0 51.4 32.5 15.1 52.5 32.4
70–74 9.6 51.8 38.6 12.6 48.4 38.9 11.9 49.4 38.7
75+ 7.5 47.4 45.0 10.0 44.6 45.5 9.3 45.5 45.2
Total 55.0 35.0 10.0 55.3 33.8 10.9 53.9 35.3 10.9
95% CI 49.6–60.3 31.4–38.7 8.1–11.9 52.4–58.3 31.8–35.7 9.7–12.1 50.9–56.9 33.3–37.2 9.7–12.0
*Vision status: Normal vision = presenting visual acuity of ≥ 6/18 in the better eye; Low vision = presenting visual acuity of < 6/18 to ≤ 3/60 in the 
better eye; Blindness = presenting visual acuity of < 3/60 in the better eye.
**Children aged 0–4 years assumed to have normal vision.BMC Ophthalmology 2007, 7:12 http://www.biomedcentral.com/1471-2415/7/12
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At present, assessment of CO is used by programmes as
the main proxy outcome indicator for vision loss related
to trachoma. However, CO is a serious end-stage compli-
cation of trachoma and is not a suitable sign for triggering
public health intervention. It is, therefore, appropriate to
routinely measure visual acuity in patients with trichiasis
to prioritise individuals most likely to benefit from sur-
gery. Visual acuity monitoring for post operative follow-
up is essential. Deterioration of vision could be used as an
indicator to strongly advocate for surgical intervention in
patients refusing surgery. Visual acuity is also a valuable
outcome in evaluating the impact of surgical intervention
since the primary purpose of trichiasis surgery is to pre-
vent vision loss.
Conclusion
We have reported severe trichiasis and high prevalence of
trachomatous vision loss among persons with trichiasis. A
half of all persons with trichiasis could be expected to
have low vision or blindness by the time they reach their
late thirties. The study revealed that nearly 90% of persons
with trichiasis have either normal or low vision in the bet-
ter eye; and therefore trichiasis surgery in likely to be sight
saving for them. There is need to urgently implement
trichiasis surgery services. In addition, challenges of pro-
viding TT surgery including poor uptake, recurrence and
provision of general anaesthetic for small children will
need to be addressed. Routine assessment of vision status
is recommended to assist in planning for trichiasis surgery
services in addition to evaluating the success of surgical
interventions in preventing vision loss. Antibiotic treat-
ment, facial cleanliness and environmental change should
also be implemented to ensure sustained reduction of
active trachoma and elimination of incident cicatrizing
trachoma and trachomatous vision loss.
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Observed and predicted distribution of vision status by age group in persons with trichiasis (n = 319) Figure 4
Observed and predicted distribution of vision status by age group in persons with trichiasis (n = 319). Vision sta-
tus: Normal vision = presenting visual acuity of ≥ 6/18 in the better eye; Low vision = presenting visual acuity of < 6/18 to ≤ 3/
60 in the better eye; Blindness = presenting visual acuity of < 3/60 in the better eye. Children aged 0–4 years assumed to have 
normal vision.
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